[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.167.142.229. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
October 12, 2005

Pay-for-Performance ResearchHow to Learn What Clinicians and Policy Makers Need to Know

Author Affiliations
 

Author Affiliation: Institute for Health Policy Studies and Department of Medicine, University of California, San Francisco.

JAMA. 2005;294(14):1821-1823. doi:10.1001/jama.294.14.1821

Pay-for-performance has become increasingly common in health care. According to recent surveys, almost 100 pay-for-performance initiatives nationwide are now sponsored by a variety of health plans, employer coalitions, and government purchasers that are intended to improve the quality of care provided.1

However, the rationale for pay-for-performance comes almost entirely from experience with incentives in other industries. Only 9 randomized controlled trials (RCTs) of pay-for-performance have been reported in the literature.2 Even these studies are not clearly applicable to current pay-for-performance because they all focus on performance for a single indicator or a single aspect of care (eg, preventive care), whereas most current pay-for-performance initiatives use multiple indicators for multiple conditions and types of care.1 Moreover, most studies have important flaws in reporting, such as the failure to note the market share of the organization offering the incentive in the practices of the providers being studied. Because pay-for-performance programs have targeted both individual clinicians and clinical organizations such as hospitals, medical groups, and nursing homes, the collective term “provider” is used herein to refer to all potential parties.

First Page Preview View Large
First page PDF preview
First page PDF preview
×